Photograph: Anthony Tieuli for STAT; Styling: Alissa Ambrose/STAT

STAT+ | Alcohol is wreaking havoc on U.S. public health. American society looks the other way

How is a drug that kills 500 people a day not seen as a public health emergency? Part 1 of 'The Deadliest Drug,' a series on alcohol and public health.

By Lev Facher and Isabella Cueto

STAT+ | Makary departs FDA amid turmoil as Diamantas, agency’s top food official, steps in

Marty Makary is the latest top Trump administration health official to depart, creating another opening in RFK Jr.'s department.

By Lizzy Lawrence

STAT+ | Despite its toll, alcohol is still an awkward subject in the doctor’s office

Alcohol screening is on par with flu shots for effectiveness. Part 2 of the series 'Deadliest Drug' explores why doctors are reluctant to bring up drinking.

By Amanda Erickson and Isabella Cueto

Adobe

PCOS’s new name is PMOS, a small letter change that required a big scientific process

After hearing from 22,000 people over 11 years, polycystic ovary syndrome (PCOS) was renamed polyendocrine metabolic ovarian syndrome (PMOS).

By Annalisa Merelli

STAT+ | Capsida says it still doesn’t know what caused gene therapy death 

Capsida Biotherapeutics discloses fatal gene therapy targeted ADAM-15, a receptor others avoided, says it still doesn't know precise cause of death.

By Jason Mast

6 takeaways from STAT’s investigation into the U.S. alcohol epidemic

'Deadliest Drug' series explores how alcohol kills more Americans than all other drugs combined, and why that's not seen as a public health emergency.

By Isabella Cueto and Lev Facher

Adobe

STAT+ | In the battle of sepsis algorithms, performance alone doesn’t predict victory

How Medicare payment rules and FDA clearance could level the playing field for new AI sepsis models competing against incumbents like Epic Systems.

By Katie Palmer

STAT+ | Opinion: Pharma and biotech leaders are destroying their own industry

With their focus on China, American biotech leaders are prioritizing short-term profits over the long-term stability of the industry.

By Olivia Kosloff